Allogene Therapeutics (ALLO) Interest Coverage Ratio Growth (1y) (2019 - 2026)
Allogene Therapeutics (ALLO) Interest Coverage Ratio Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 787.12% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -100.36% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 73.00% |
| 10 | Allogene Therapeutics | 437.33 Mn | 437.33 Mn | - | 90.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 90.31% |
| Dec 31, 2025 | 81.86% |
| Sep 30, 2025 | 64.97% |
| Jun 30, 2025 | -289.31% |
| Mar 31, 2025 | 9.32% |
| Dec 31, 2024 | -5,364.71% |
| Sep 30, 2024 | -190.79% |
| Jun 30, 2024 | 74.40% |
| Mar 31, 2024 | 84.54% |
| Dec 31, 2023 | 201.54% |
| Sep 30, 2023 | -215.18% |
| Jun 30, 2023 | 4.82% |
| Mar 31, 2023 | 17.44% |
| Dec 31, 2022 | -1,654.98% |
| Sep 30, 2022 | 38.43% |
| Jun 30, 2022 | -151.57% |
| Mar 31, 2022 | -20.50% |
| Dec 31, 2021 | 100.99% |
| Sep 30, 2021 | -207.03% |
| Jun 30, 2021 | -331.93% |